<DOC>
	<DOCNO>NCT01167491</DOCNO>
	<brief_summary>The investigator recently show abnormal expansion NK-like CD4+ T cell Wegener 's granulomatosis ( WG ) , mainly diffuse vasculitis presentation . These cell express assortment activate NK cell receptor signal partner , particular DAP12 . The investigator hypothesize DAP12 , downstream signal target DAP12 , miss link different cell component involve WG ( neutrophil , macrophage , CD4 T cell ) .</brief_summary>
	<brief_title>Study One Protein Implicated Wegener Disease</brief_title>
	<detailed_description>The investigator test hypothesis `` DAP-12 gain-of-function '' quantitative ( mRNA protein ) qualitative ( DNA , signal cellular activation ) analysis DAP12 signal pathway WG patient localize ( group 1 ; n=30 ) diffuse WG ( group 2 ; n=30 ) comparison patient micro polyangitis ( group 3 ; n=30 ) , sarcoidosis ( group 4 ; n=30 ) , healthy blood donor ( group 5 ; n=30 ) . Blood sample collect routine medical visit . These result may help design future therapeutic strategy base modulation specific intra-cellular pathway involve disease .</detailed_description>
	<mesh_term>Granulomatosis Polyangiitis</mesh_term>
	<criteria>Group 1 : WG , granulomatous lesion limit upper airway lung evidence generalize vasculitis , ± biopsy , ± antiPR3 ANCA Group 2 : WG granulomatous lesion plus vasculitis expression ( renal , neurological , skin , gut heart involvement ) , ± biopsy , ± antiPR3 ANCA Group 3 : Necrotizing vasculitis granulomatous lesion , ± PAUCI immune glomerulonephritis , ± antiMPO ANCA Group 4 : clinical presentation compatible sarcoidosis , ± biopsy , ± ECA elevate ± tuberculin anergy &lt; 18 year Pregnancy breastfeed Absence sign inform consent No affiliation insurance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Wegener</keyword>
	<keyword>CD4+ T cell</keyword>
	<keyword>DAP12</keyword>
	<keyword>NKG2D</keyword>
</DOC>